Arcus Biosciences, Inc. (RCUS)
22.20
+0.29
(+1.32%)
USD |
NYSE |
Dec 16, 16:00
22.29
+0.09
(+0.41%)
Pre-Market: 06:29
Arcus Biosciences Accounts Payable (Quarterly): 42.00M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 808.00M |
| Actinium Pharmaceuticals, Inc. | 6.224M |
| Merck & Co., Inc. | 4.147B |
| AbbVie, Inc. | 33.36B |
| Karyopharm Therapeutics, Inc. | 5.392M |